Evidence map›Paper›PMID 41238567›Full record

ArticleScientific reports2025

Comparison of three multiplex immunoassays for biomarker analysis in stratum corneum tape strips.

Nariman K A Metwally, Florentine de Boer, Jop Vreeken, Wouter Ouwerkerk, Thomas Rustemeyer, Henk F van der Molen, Sanja Kezic

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nariman K A Metwally *Public and Occupational Health Department, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research, Amsterdam, The Netherlands.
Florentine de Boer *Public and Occupational Health Department, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research, Amsterdam, The Netherlands.
Jop VreekenDepartment of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.
Wouter OuwerkerkDepartment of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.
Thomas RustemeyerDermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, Noord-Holland, The Netherlands.
Henk F van der MolenPublic and Occupational Health Department, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research, Amsterdam, The Netherlands.
Sanja KezicPublic and Occupational Health Department, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research, Amsterdam, The Netherlands. s.kezic@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study compared three multiplex immunoassay platforms, Meso Scale Discovery (MSD), NULISA, and Olink, for detecting protein markers in stratum corneum tape strips, a non-invasive sampling method challenged by low protein yield. We evaluated 30 shared proteins across all three platforms, plus 9 additional proteins shared only between MSD and NULISA, and 1 between MSD and OLINK, using samples from non-lesional skin and skin affected by patch test-induced irritant and allergic contact dermatitis, and clinical hand dermatitis. Proteins were considered detectable when more than 50% of samples exceeded the platform's protein-specific detection limit. MSD demonstrated the highest sensitivity, detecting 70% of shared proteins, followed by NULISA (30%) and Olink (16.7%). Four proteins, CXCL8, VEGFA, IL18, and CCL2, were detected by all three platforms with interclass correlation coefficients ranging from 0.5 to 0.86. The three platforms exhibited similar differential expression patterns between control and dermatitis-affected skin, supporting overall concordance. MSD uniquely provided absolute protein concentrations, enabling normalization for variable SC content, while NULISA and Olink required smaller sample volumes and fewer assay runs. Generalizability to other diseases and biomarkers requires further investigation.

Indexed as

BiomarkersEpidermisSkinAdultChemokine CCL2Dermatitis, Allergic ContactFemaleHumansImmunoassayInterleukin-8MaleMiddle AgedVascular Endothelial Growth Factor ABiomarkersChemokine CCL2Interleukin-8Vascular Endothelial Growth Factor AVEGFA protein, humanContact dermatitisMultiplex immunoassaysStratum corneum tape stripping

Identifiers

PMID41238567
PMCPMC12618483

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.